Immune modulatory effects of oncogenic KRAS in cancer
Oncogenic KRAS mutations are the most frequent mutations in human cancer, but most
difficult to target. While sustained proliferation caused by oncogenic KRAS-downstream …
difficult to target. While sustained proliferation caused by oncogenic KRAS-downstream …
Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer
F Pellati, V Borgonetti, V Brighenti… - BioMed research …, 2018 - Wiley Online Library
In the last decades, a lot of attention has been paid to the compounds present in medicinal
Cannabis sativa L., such as Δ9‐tetrahydrocannabinol (Δ9‐THC) and cannabidiol (CBD) …
Cannabis sativa L., such as Δ9‐tetrahydrocannabinol (Δ9‐THC) and cannabidiol (CBD) …
Protection against chemotherapy-and radiotherapy-induced side effects: A review based on the mechanisms and therapeutic opportunities of phytochemicals
YQ Liu, XL Wang, DH He, YX Cheng - Phytomedicine, 2021 - Elsevier
Background Although great achievements have been made in the field of cancer therapy,
chemotherapy and radiotherapy remain the mainstay cancer therapeutic modalities …
chemotherapy and radiotherapy remain the mainstay cancer therapeutic modalities …
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of …
JM Banales, V Cardinale, G Carpino… - Nature reviews …, 2016 - research.ed.ac.uk
Cholangiocarcinoma (CCA) is a heterogeneous group of malignancies with features of
biliary tract differentiation. CCA is the second most common primary liver tumour and the …
biliary tract differentiation. CCA is the second most common primary liver tumour and the …
EMT and inflammation: inseparable actors of cancer progression
Tumors can be depicted as wounds that never heal, and are infiltrated by a large array of
inflammatory and immune cells. Tumor‐associated chronic inflammation is a hallmark of …
inflammatory and immune cells. Tumor‐associated chronic inflammation is a hallmark of …
Inflammation and cancer: advances and new agents
SM Crusz, FR Balkwill - Nature reviews Clinical oncology, 2015 - nature.com
Tumour-promoting inflammation is considered one of the enabling characteristics of cancer
development. Chronic inflammatory disease increases the risk of some cancers, and strong …
development. Chronic inflammatory disease increases the risk of some cancers, and strong …
Cancer-related inflammation and treatment effectiveness
CI Diakos, KA Charles, DC McMillan… - The Lancet …, 2014 - thelancet.com
Inflammation is a recognised hallmark of cancer that substantially contributes to the
development and progression of malignancies. In established cancers, there is increasing …
development and progression of malignancies. In established cancers, there is increasing …
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
Inflammation is a fundamental innate immune response to perturbed tissue homeostasis.
Chronic inflammatory processes affect all stages of tumour development as well as therapy …
Chronic inflammatory processes affect all stages of tumour development as well as therapy …
[HTML][HTML] The dual role of iNOS in cancer
Nitric oxide (NO) is one of the 10 smallest molecules found in nature. It is a simple gaseous
free radical whose predominant functions is that of a messenger through cGMP. In …
free radical whose predominant functions is that of a messenger through cGMP. In …
Crosstalk between peroxisome proliferator-activated receptor gamma and the canonical WNT/β-catenin pathway in chronic inflammation and oxidative stress during …
A Vallée, Y Lecarpentier - Frontiers in immunology, 2018 - frontiersin.org
Inflammation and oxidative stress are common and co-substantial pathological processes
accompanying, promoting, and even initiating numerous cancers. The canonical WNT/β …
accompanying, promoting, and even initiating numerous cancers. The canonical WNT/β …